Update shared on 12 Dec 2025
Fair value Decreased 0.32%Analysts have adjusted their price target on Becle, de slightly lower to approximately $27.89 from about $27.98. This reflects modestly higher long-term discount assumptions that partially offset incremental improvements in expected revenue growth, profit margins, and future valuation multiples.
Valuation Changes
- Fair Value Estimate edged down slightly from MX$27.98 to MX$27.89, reflecting a modestly more conservative valuation.
- Discount Rate remained effectively unchanged at 14.27 percent, indicating a stable view of Becle’s risk profile.
- Revenue Growth increased marginally from 4.95 percent to about 4.95 percent, pointing to a slightly more optimistic top line outlook.
- Net Profit Margin improved slightly from 14.92 percent to around 14.95 percent, suggesting modest efficiency gains.
- Future P/E declined slightly from 19.36x to about 19.26x, implying a marginally lower multiple applied to expected earnings.
Have other thoughts on Becle. de?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.